Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma

Ann Hematol. 2019 Jun;98(6):1519-1520. doi: 10.1007/s00277-018-3588-y. Epub 2018 Dec 13.

¹ Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. wolfgang.lamm@meduniwien.ac.at.
² Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
³ Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
⁴ Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

No abstract available

Publication types